Artivion to Participate in the Oppenheimer 35th Annual Healthcare MedTech & Services Conference

Artivion (NYSE: AORT), a cardiac and vascular surgery company specializing in aortic disease, has announced its participation in the Oppenheimer 35th Annual Healthcare MedTech & Services Conference.

Rhea-AI Summary

Artivion (NYSE: AORT), a cardiac and vascular surgery company specializing in aortic disease, has announced its participation in the Oppenheimer 35th Annual Healthcare MedTech & Services Conference. The company will engage in a virtual fireside chat on March 18, 2025 at 10:40 a.m. ET.

Investors and interested parties can access the live webcast through the Investors page on Artivion's website (www.artivion.com). The recorded session will remain available for replay on the website for 90 days following the event.

Argus Session date unavailable

+1.16% session move Open Argus

Details

News Market Reaction – AORT

The recorded move for AORT in the trading session of this news was +1.16%.

Data tracked by StockTitan Argus. Session date unavailable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

ATLANTA, March 4, 2025 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced that it will participate virtually at the upcoming Oppenheimer 35^th Annual Healthcare MedTech & Services Conference. The Company's virtual fireside chat is scheduled to begin at 10:40 a.m. ET on March 18, 2025.  

A live webcast of the virtual fireside chat will be accessible through Artivion's website, www.artivion.com, on the Investors page.  An archived copy of the webcast will be available for 90 days on the same website. 

About Artivion, Inc.

Headquartered in suburban Atlanta, Georgia, Artivion, Inc. is a medical device company focused on developing simple, elegant solutions that address cardiac and vascular surgeons' most difficult challenges in treating patients with aortic diseases. Artivion's four major groups of products include: aortic stent grafts, surgical sealants, On-X mechanical heart valves, and implantable cardiac and vascular human tissues. Artivion markets and sells products in more than 100 countries worldwide. For additional information about Artivion, visit our website, www.Artivion.com.

Contacts:

Artivion	Gilmartin Group LLC
Lance A. Berry	Brian Johnston / Laine Morgan
Executive Vice President &	Phone: 332-895-3222
Chief Financial Officer	investors@artivion.com
Phone: 770-419-3355

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/artivion-to-participate-in-the-oppenheimer-35th-annual-healthcare-medtech--services-conference-302391959.html

SOURCE Artivion

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When is Artivion (AORT) presenting at the Oppenheimer Healthcare Conference 2025?

Artivion (AORT) will present on March 18, 2025, at 10:40 a.m. ET during a virtual fireside chat.

How can investors watch Artivion's (AORT) Oppenheimer Conference presentation?

Investors can watch the live webcast through Artivion's website (www.artivion.com) on the Investors page.

How long will Artivion's (AORT) Oppenheimer Conference presentation be available for replay?

The webcast recording will be available for 90 days on Artivion's website after the presentation.

What type of conference is Artivion (AORT) participating in March 2025?

Artivion is participating in the Oppenheimer 35th Annual Healthcare MedTech & Services Conference, which is being held virtually.